nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolic acid—UGT2B7—urinary bladder cancer	0.566	1	CbGaD
Mycophenolic acid—UGT2B7—Epirubicin—urinary bladder cancer	0.073	0.598	CbGbCtD
Mycophenolic acid—UGT1A1—Etoposide—urinary bladder cancer	0.0492	0.402	CbGbCtD
Mycophenolic acid—UGT1A1—urine—urinary bladder cancer	0.00534	0.104	CbGeAlD
Mycophenolic acid—UGT1A6—prostate gland—urinary bladder cancer	0.00518	0.101	CbGeAlD
Mycophenolic acid—UGT1A7—renal system—urinary bladder cancer	0.00454	0.0886	CbGeAlD
Mycophenolic acid—Mycophenolate mofetil—UGT2B7—urinary bladder cancer	0.00434	1	CrCbGaD
Mycophenolic acid—IMPDH2—prostate gland—urinary bladder cancer	0.00248	0.0484	CbGeAlD
Mycophenolic acid—IMPDH1—prostate gland—urinary bladder cancer	0.00246	0.0481	CbGeAlD
Mycophenolic acid—UGT2B7—prostate gland—urinary bladder cancer	0.00225	0.044	CbGeAlD
Mycophenolic acid—IMPDH2—seminal vesicle—urinary bladder cancer	0.0021	0.0409	CbGeAlD
Mycophenolic acid—IMPDH1—seminal vesicle—urinary bladder cancer	0.00208	0.0407	CbGeAlD
Mycophenolic acid—UGT1A1—prostate gland—urinary bladder cancer	0.00192	0.0374	CbGeAlD
Mycophenolic acid—UGT1A9—renal system—urinary bladder cancer	0.00191	0.0372	CbGeAlD
Mycophenolic acid—IMPDH2—smooth muscle tissue—urinary bladder cancer	0.00176	0.0343	CbGeAlD
Mycophenolic acid—IMPDH1—smooth muscle tissue—urinary bladder cancer	0.00174	0.0341	CbGeAlD
Mycophenolic acid—IMPDH2—renal system—urinary bladder cancer	0.00169	0.033	CbGeAlD
Mycophenolic acid—IMPDH1—renal system—urinary bladder cancer	0.00168	0.0328	CbGeAlD
Mycophenolic acid—IMPDH2—urethra—urinary bladder cancer	0.00166	0.0324	CbGeAlD
Mycophenolic acid—IMPDH1—urethra—urinary bladder cancer	0.00165	0.0322	CbGeAlD
Mycophenolic acid—UGT2B7—renal system—urinary bladder cancer	0.00154	0.03	CbGeAlD
Mycophenolic acid—IMPDH2—female reproductive system—urinary bladder cancer	0.00135	0.0264	CbGeAlD
Mycophenolic acid—IMPDH1—female reproductive system—urinary bladder cancer	0.00134	0.0263	CbGeAlD
Mycophenolic acid—UGT1A1—renal system—urinary bladder cancer	0.00131	0.0255	CbGeAlD
Mycophenolic acid—UGT2B7—female reproductive system—urinary bladder cancer	0.00123	0.024	CbGeAlD
Mycophenolic acid—IMPDH2—vagina—urinary bladder cancer	0.00122	0.0239	CbGeAlD
Mycophenolic acid—IMPDH1—vagina—urinary bladder cancer	0.00122	0.0237	CbGeAlD
Mycophenolic acid—IMPDH2—lymph node—urinary bladder cancer	0.000792	0.0155	CbGeAlD
Mycophenolic acid—IMPDH1—lymph node—urinary bladder cancer	0.000787	0.0154	CbGeAlD
Mycophenolic acid—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000155	0.00133	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000155	0.00133	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Biological oxidations—GSTP1—urinary bladder cancer	0.000155	0.00133	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—GSTZ1—urinary bladder cancer	0.000153	0.00131	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000153	0.00131	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—CYP4B1—urinary bladder cancer	0.000146	0.00126	CbGpPWpGaD
Mycophenolic acid—UGT1A9—PPAR Alpha Pathway—CCND1—urinary bladder cancer	0.000146	0.00125	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—GSTO2—urinary bladder cancer	0.000145	0.00124	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—UGT2B7—urinary bladder cancer	0.000145	0.00124	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—NAT1—urinary bladder cancer	0.000145	0.00124	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Phase II conjugation—GSTP1—urinary bladder cancer	0.000144	0.00124	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Biological oxidations—GSTM1—urinary bladder cancer	0.000142	0.00122	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00014	0.0012	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—SLC19A1—urinary bladder cancer	0.000138	0.00119	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—PRSS3—urinary bladder cancer	0.000135	0.00116	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Phase II conjugation—GSTM1—urinary bladder cancer	0.000133	0.00114	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—UGT2B7—urinary bladder cancer	0.000132	0.00114	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—CYP4B1—urinary bladder cancer	0.00013	0.00112	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Biological oxidations—NAT2—urinary bladder cancer	0.000128	0.0011	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Biological oxidations—NAT2—urinary bladder cancer	0.000128	0.0011	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000126	0.00108	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000126	0.00108	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Biological oxidations—HPGDS—urinary bladder cancer	0.000126	0.00108	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—SLC19A1—urinary bladder cancer	0.000123	0.00106	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Biological oxidations—GSTT1—urinary bladder cancer	0.000122	0.00105	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—PRSS3—urinary bladder cancer	0.00012	0.00103	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—CYP4B1—urinary bladder cancer	0.000119	0.00102	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Phase II conjugation—GSTP1—urinary bladder cancer	0.000117	0.00101	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Phase II conjugation—GSTP1—urinary bladder cancer	0.000117	0.00101	CbGpPWpGaD
Mycophenolic acid—UGT1A9—PPAR Alpha Pathway—MYC—urinary bladder cancer	0.000117	0.001	CbGpPWpGaD
Mycophenolic acid—UGT2B7—NRF2 pathway—NQO1—urinary bladder cancer	0.000115	0.000991	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—SLC19A1—urinary bladder cancer	0.000113	0.000967	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—PRSS3—urinary bladder cancer	0.00011	0.000943	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Phase II conjugation—GSTM1—urinary bladder cancer	0.000108	0.000925	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Phase II conjugation—GSTM1—urinary bladder cancer	0.000108	0.000925	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—TYMP—urinary bladder cancer	0.000108	0.000924	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Biological oxidations—HPGDS—urinary bladder cancer	0.000102	0.000876	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Biological oxidations—HPGDS—urinary bladder cancer	0.000102	0.000876	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Biological oxidations—GSTT1—urinary bladder cancer	9.9e-05	0.00085	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Biological oxidations—GSTT1—urinary bladder cancer	9.9e-05	0.00085	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—NAT2—urinary bladder cancer	9.73e-05	0.000836	CbGpPWpGaD
Mycophenolic acid—UGT2B7—NRF2 pathway—GSTP1—urinary bladder cancer	9.62e-05	0.000826	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—TYMP—urinary bladder cancer	9.59e-05	0.000824	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—GSTZ1—urinary bladder cancer	9.47e-05	0.000814	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	9.46e-05	0.000812	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	9.46e-05	0.000812	CbGpPWpGaD
Mycophenolic acid—UGT1A1—NRF2 pathway—NQO1—urinary bladder cancer	9.38e-05	0.000805	CbGpPWpGaD
Mycophenolic acid—UGT1A9—NRF2 pathway—NQO1—urinary bladder cancer	9.38e-05	0.000805	CbGpPWpGaD
Mycophenolic acid—UGT1A9—PPARA activates gene expression—NCOR1—urinary bladder cancer	9.01e-05	0.000774	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—GSTO2—urinary bladder cancer	8.98e-05	0.000771	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—NAT1—urinary bladder cancer	8.98e-05	0.000771	CbGpPWpGaD
Mycophenolic acid—UGT2B7—NRF2 pathway—GSTM1—urinary bladder cancer	8.84e-05	0.000759	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—urinary bladder cancer	8.82e-05	0.000758	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—TYMP—urinary bladder cancer	8.77e-05	0.000753	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—NAT2—urinary bladder cancer	8.67e-05	0.000745	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	8.49e-05	0.000729	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	8.49e-05	0.000729	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Biological oxidations—GSTP1—urinary bladder cancer	8.44e-05	0.000725	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—RRM2—urinary bladder cancer	8.4e-05	0.000722	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.32e-05	0.000715	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	8.25e-05	0.000709	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	8.25e-05	0.000709	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—UGT2B7—urinary bladder cancer	8.22e-05	0.000706	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—NAT2—urinary bladder cancer	7.93e-05	0.000681	CbGpPWpGaD
Mycophenolic acid—UGT1A1—NRF2 pathway—GSTP1—urinary bladder cancer	7.82e-05	0.000672	CbGpPWpGaD
Mycophenolic acid—UGT1A9—NRF2 pathway—GSTP1—urinary bladder cancer	7.82e-05	0.000672	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—HPGDS—urinary bladder cancer	7.78e-05	0.000668	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—ENO2—urinary bladder cancer	7.78e-05	0.000668	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Biological oxidations—GSTM1—urinary bladder cancer	7.76e-05	0.000666	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.65e-05	0.000657	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—GSTT1—urinary bladder cancer	7.55e-05	0.000648	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—RRM2—urinary bladder cancer	7.49e-05	0.000643	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—CYP4B1—urinary bladder cancer	7.4e-05	0.000635	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	7.37e-05	0.000633	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	7.23e-05	0.000621	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	7.23e-05	0.000621	CbGpPWpGaD
Mycophenolic acid—UGT1A1—NRF2 pathway—GSTM1—urinary bladder cancer	7.19e-05	0.000617	CbGpPWpGaD
Mycophenolic acid—UGT1A9—NRF2 pathway—GSTM1—urinary bladder cancer	7.19e-05	0.000617	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—SLC19A1—urinary bladder cancer	6.99e-05	0.0006	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—ENO2—urinary bladder cancer	6.93e-05	0.000596	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—HPGDS—urinary bladder cancer	6.93e-05	0.000596	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	6.89e-05	0.000592	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	6.89e-05	0.000592	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Biological oxidations—GSTP1—urinary bladder cancer	6.86e-05	0.000589	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Biological oxidations—GSTP1—urinary bladder cancer	6.86e-05	0.000589	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—RRM2—urinary bladder cancer	6.85e-05	0.000588	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—PRSS3—urinary bladder cancer	6.81e-05	0.000585	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.76e-05	0.000581	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.76e-05	0.000581	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—GSTT1—urinary bladder cancer	6.73e-05	0.000578	CbGpPWpGaD
Mycophenolic acid—UGT1A9—PPARA activates gene expression—PPARG—urinary bladder cancer	6.46e-05	0.000555	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—HPGDS—urinary bladder cancer	6.34e-05	0.000545	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—ENO2—urinary bladder cancer	6.34e-05	0.000545	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	6.32e-05	0.000543	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Biological oxidations—GSTM1—urinary bladder cancer	6.3e-05	0.000541	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Biological oxidations—GSTM1—urinary bladder cancer	6.3e-05	0.000541	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—NQO1—urinary bladder cancer	6.27e-05	0.000539	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.22e-05	0.000534	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.22e-05	0.000534	CbGpPWpGaD
Mycophenolic acid—UGT1A9—PPARA activates gene expression—CREBBP—urinary bladder cancer	6.2e-05	0.000533	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—GSTT1—urinary bladder cancer	6.15e-05	0.000528	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	6.08e-05	0.000522	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	6.07e-05	0.000522	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—NQO1—urinary bladder cancer	5.59e-05	0.00048	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—TYMP—urinary bladder cancer	5.44e-05	0.000467	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—GSTP1—urinary bladder cancer	5.23e-05	0.000449	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—GSTZ1—urinary bladder cancer	5.17e-05	0.000444	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—NQO1—urinary bladder cancer	5.11e-05	0.000439	CbGpPWpGaD
Mycophenolic acid—Conjunctivitis—Doxorubicin—urinary bladder cancer	4.96e-05	0.000354	CcSEcCtD
Mycophenolic acid—Urinary tract infection—Doxorubicin—urinary bladder cancer	4.96e-05	0.000354	CcSEcCtD
Mycophenolic acid—Haemorrhage—Epirubicin—urinary bladder cancer	4.95e-05	0.000354	CcSEcCtD
Mycophenolic acid—Hepatitis—Epirubicin—urinary bladder cancer	4.95e-05	0.000354	CcSEcCtD
Mycophenolic acid—Eye disorder—Methotrexate—urinary bladder cancer	4.94e-05	0.000353	CcSEcCtD
Mycophenolic acid—Diarrhoea—Fluorouracil—urinary bladder cancer	4.94e-05	0.000353	CcSEcCtD
Mycophenolic acid—Tinnitus—Methotrexate—urinary bladder cancer	4.93e-05	0.000352	CcSEcCtD
Mycophenolic acid—Hypoaesthesia—Epirubicin—urinary bladder cancer	4.92e-05	0.000352	CcSEcCtD
Mycophenolic acid—UGT1A6—Metabolism—NAT2—urinary bladder cancer	4.92e-05	0.000423	CbGpPWpGaD
Mycophenolic acid—Asthenia—Cisplatin—urinary bladder cancer	4.91e-05	0.000351	CcSEcCtD
Mycophenolic acid—Pharyngitis—Epirubicin—urinary bladder cancer	4.91e-05	0.000351	CcSEcCtD
Mycophenolic acid—Cardiac disorder—Methotrexate—urinary bladder cancer	4.91e-05	0.000351	CcSEcCtD
Mycophenolic acid—UGT2B7—Metabolism—GSTO2—urinary bladder cancer	4.9e-05	0.000421	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—NAT1—urinary bladder cancer	4.9e-05	0.000421	CbGpPWpGaD
Mycophenolic acid—Sweating—Doxorubicin—urinary bladder cancer	4.89e-05	0.000349	CcSEcCtD
Mycophenolic acid—Urinary tract disorder—Epirubicin—urinary bladder cancer	4.89e-05	0.000349	CcSEcCtD
Mycophenolic acid—Oedema peripheral—Epirubicin—urinary bladder cancer	4.88e-05	0.000348	CcSEcCtD
Mycophenolic acid—Haematuria—Doxorubicin—urinary bladder cancer	4.86e-05	0.000348	CcSEcCtD
Mycophenolic acid—Connective tissue disorder—Epirubicin—urinary bladder cancer	4.86e-05	0.000348	CcSEcCtD
Mycophenolic acid—IMPDH2—Metabolism—TYMS—urinary bladder cancer	4.86e-05	0.000418	CbGpPWpGaD
Mycophenolic acid—Urethral disorder—Epirubicin—urinary bladder cancer	4.85e-05	0.000347	CcSEcCtD
Mycophenolic acid—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	4.82e-05	0.000345	CcSEcCtD
Mycophenolic acid—Epistaxis—Doxorubicin—urinary bladder cancer	4.81e-05	0.000344	CcSEcCtD
Mycophenolic acid—IMPDH2—Metabolism—NCOR1—urinary bladder cancer	4.81e-05	0.000413	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—GSTM1—urinary bladder cancer	4.81e-05	0.000413	CbGpPWpGaD
Mycophenolic acid—Angiopathy—Methotrexate—urinary bladder cancer	4.8e-05	0.000343	CcSEcCtD
Mycophenolic acid—Sinusitis—Doxorubicin—urinary bladder cancer	4.79e-05	0.000342	CcSEcCtD
Mycophenolic acid—Dizziness—Fluorouracil—urinary bladder cancer	4.78e-05	0.000341	CcSEcCtD
Mycophenolic acid—Visual impairment—Epirubicin—urinary bladder cancer	4.77e-05	0.000341	CcSEcCtD
Mycophenolic acid—Mediastinal disorder—Methotrexate—urinary bladder cancer	4.77e-05	0.000341	CcSEcCtD
Mycophenolic acid—Agranulocytosis—Doxorubicin—urinary bladder cancer	4.76e-05	0.00034	CcSEcCtD
Mycophenolic acid—Chills—Methotrexate—urinary bladder cancer	4.75e-05	0.000339	CcSEcCtD
Mycophenolic acid—Diarrhoea—Cisplatin—urinary bladder cancer	4.68e-05	0.000335	CcSEcCtD
Mycophenolic acid—Alopecia—Methotrexate—urinary bladder cancer	4.67e-05	0.000334	CcSEcCtD
Mycophenolic acid—Vomiting—Gemcitabine—urinary bladder cancer	4.67e-05	0.000334	CcSEcCtD
Mycophenolic acid—UGT1A7—Metabolism—GSTP1—urinary bladder cancer	4.66e-05	0.0004	CbGpPWpGaD
Mycophenolic acid—Bradycardia—Doxorubicin—urinary bladder cancer	4.66e-05	0.000333	CcSEcCtD
Mycophenolic acid—Mental disorder—Methotrexate—urinary bladder cancer	4.63e-05	0.000331	CcSEcCtD
Mycophenolic acid—Rash—Gemcitabine—urinary bladder cancer	4.63e-05	0.000331	CcSEcCtD
Mycophenolic acid—Dermatitis—Gemcitabine—urinary bladder cancer	4.63e-05	0.000331	CcSEcCtD
Mycophenolic acid—Eye disorder—Epirubicin—urinary bladder cancer	4.63e-05	0.000331	CcSEcCtD
Mycophenolic acid—Tinnitus—Epirubicin—urinary bladder cancer	4.61e-05	0.00033	CcSEcCtD
Mycophenolic acid—Malnutrition—Methotrexate—urinary bladder cancer	4.6e-05	0.000329	CcSEcCtD
Mycophenolic acid—IMPDH2—Metabolism—GPX1—urinary bladder cancer	4.6e-05	0.000395	CbGpPWpGaD
Mycophenolic acid—Haemoglobin—Doxorubicin—urinary bladder cancer	4.6e-05	0.000329	CcSEcCtD
Mycophenolic acid—Headache—Gemcitabine—urinary bladder cancer	4.6e-05	0.000329	CcSEcCtD
Mycophenolic acid—Cardiac disorder—Epirubicin—urinary bladder cancer	4.59e-05	0.000328	CcSEcCtD
Mycophenolic acid—Vomiting—Fluorouracil—urinary bladder cancer	4.59e-05	0.000328	CcSEcCtD
Mycophenolic acid—Rhinitis—Doxorubicin—urinary bladder cancer	4.59e-05	0.000328	CcSEcCtD
Mycophenolic acid—Haemorrhage—Doxorubicin—urinary bladder cancer	4.58e-05	0.000327	CcSEcCtD
Mycophenolic acid—Hepatitis—Doxorubicin—urinary bladder cancer	4.58e-05	0.000327	CcSEcCtD
Mycophenolic acid—Hypoaesthesia—Doxorubicin—urinary bladder cancer	4.56e-05	0.000326	CcSEcCtD
Mycophenolic acid—Rash—Fluorouracil—urinary bladder cancer	4.55e-05	0.000325	CcSEcCtD
Mycophenolic acid—Dermatitis—Fluorouracil—urinary bladder cancer	4.55e-05	0.000325	CcSEcCtD
Mycophenolic acid—Pharyngitis—Doxorubicin—urinary bladder cancer	4.54e-05	0.000325	CcSEcCtD
Mycophenolic acid—Headache—Fluorouracil—urinary bladder cancer	4.52e-05	0.000323	CcSEcCtD
Mycophenolic acid—Urinary tract disorder—Doxorubicin—urinary bladder cancer	4.52e-05	0.000323	CcSEcCtD
Mycophenolic acid—IMPDH2—Metabolism—ERCC2—urinary bladder cancer	4.52e-05	0.000388	CbGpPWpGaD
Mycophenolic acid—Oedema peripheral—Doxorubicin—urinary bladder cancer	4.51e-05	0.000322	CcSEcCtD
Mycophenolic acid—Asthenia—Etoposide—urinary bladder cancer	4.5e-05	0.000322	CcSEcCtD
Mycophenolic acid—Connective tissue disorder—Doxorubicin—urinary bladder cancer	4.5e-05	0.000322	CcSEcCtD
Mycophenolic acid—Angiopathy—Epirubicin—urinary bladder cancer	4.49e-05	0.000321	CcSEcCtD
Mycophenolic acid—Urethral disorder—Doxorubicin—urinary bladder cancer	4.49e-05	0.000321	CcSEcCtD
Mycophenolic acid—Mediastinal disorder—Epirubicin—urinary bladder cancer	4.46e-05	0.000319	CcSEcCtD
Mycophenolic acid—Back pain—Methotrexate—urinary bladder cancer	4.45e-05	0.000318	CcSEcCtD
Mycophenolic acid—Chills—Epirubicin—urinary bladder cancer	4.44e-05	0.000317	CcSEcCtD
Mycophenolic acid—Pruritus—Etoposide—urinary bladder cancer	4.44e-05	0.000317	CcSEcCtD
Mycophenolic acid—Arrhythmia—Epirubicin—urinary bladder cancer	4.42e-05	0.000316	CcSEcCtD
Mycophenolic acid—Visual impairment—Doxorubicin—urinary bladder cancer	4.41e-05	0.000315	CcSEcCtD
Mycophenolic acid—Alopecia—Epirubicin—urinary bladder cancer	4.37e-05	0.000313	CcSEcCtD
Mycophenolic acid—Nausea—Gemcitabine—urinary bladder cancer	4.36e-05	0.000312	CcSEcCtD
Mycophenolic acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	4.36e-05	0.000374	CbGpPWpGaD
Mycophenolic acid—Vomiting—Cisplatin—urinary bladder cancer	4.35e-05	0.000311	CcSEcCtD
Mycophenolic acid—Vision blurred—Methotrexate—urinary bladder cancer	4.34e-05	0.00031	CcSEcCtD
Mycophenolic acid—Mental disorder—Epirubicin—urinary bladder cancer	4.34e-05	0.00031	CcSEcCtD
Mycophenolic acid—UGT1A7—Metabolism—TYMS—urinary bladder cancer	4.33e-05	0.000372	CbGpPWpGaD
Mycophenolic acid—Rash—Cisplatin—urinary bladder cancer	4.32e-05	0.000309	CcSEcCtD
Mycophenolic acid—Dermatitis—Cisplatin—urinary bladder cancer	4.31e-05	0.000308	CcSEcCtD
Mycophenolic acid—Malnutrition—Epirubicin—urinary bladder cancer	4.31e-05	0.000308	CcSEcCtD
Mycophenolic acid—Diarrhoea—Etoposide—urinary bladder cancer	4.29e-05	0.000307	CcSEcCtD
Mycophenolic acid—Nausea—Fluorouracil—urinary bladder cancer	4.29e-05	0.000307	CcSEcCtD
Mycophenolic acid—UGT1A7—Metabolism—NCOR1—urinary bladder cancer	4.28e-05	0.000368	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—GSTM1—urinary bladder cancer	4.28e-05	0.000368	CbGpPWpGaD
Mycophenolic acid—Eye disorder—Doxorubicin—urinary bladder cancer	4.28e-05	0.000306	CcSEcCtD
Mycophenolic acid—Ill-defined disorder—Methotrexate—urinary bladder cancer	4.27e-05	0.000305	CcSEcCtD
Mycophenolic acid—Tinnitus—Doxorubicin—urinary bladder cancer	4.27e-05	0.000305	CcSEcCtD
Mycophenolic acid—IMPDH1—Metabolism—GSTP1—urinary bladder cancer	4.26e-05	0.000366	CbGpPWpGaD
Mycophenolic acid—Anaemia—Methotrexate—urinary bladder cancer	4.25e-05	0.000304	CcSEcCtD
Mycophenolic acid—Cardiac disorder—Doxorubicin—urinary bladder cancer	4.25e-05	0.000304	CcSEcCtD
Mycophenolic acid—IMPDH2—Metabolism—MTHFR—urinary bladder cancer	4.25e-05	0.000365	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—RRM2—urinary bladder cancer	4.25e-05	0.000365	CbGpPWpGaD
Mycophenolic acid—Flatulence—Epirubicin—urinary bladder cancer	4.25e-05	0.000303	CcSEcCtD
Mycophenolic acid—Tension—Epirubicin—urinary bladder cancer	4.23e-05	0.000302	CcSEcCtD
Mycophenolic acid—UGT1A9—PPARA activates gene expression—EP300—urinary bladder cancer	4.23e-05	0.000363	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—GSTZ1—urinary bladder cancer	4.2e-05	0.000361	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—GSTZ1—urinary bladder cancer	4.2e-05	0.000361	CbGpPWpGaD
Mycophenolic acid—Nervousness—Epirubicin—urinary bladder cancer	4.18e-05	0.000299	CcSEcCtD
Mycophenolic acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	4.18e-05	0.000359	CbGpPWpGaD
Mycophenolic acid—Back pain—Epirubicin—urinary bladder cancer	4.17e-05	0.000298	CcSEcCtD
Mycophenolic acid—Angiopathy—Doxorubicin—urinary bladder cancer	4.15e-05	0.000297	CcSEcCtD
Mycophenolic acid—Malaise—Methotrexate—urinary bladder cancer	4.15e-05	0.000297	CcSEcCtD
Mycophenolic acid—Dizziness—Etoposide—urinary bladder cancer	4.15e-05	0.000296	CcSEcCtD
Mycophenolic acid—Muscle spasms—Epirubicin—urinary bladder cancer	4.14e-05	0.000296	CcSEcCtD
Mycophenolic acid—Vertigo—Methotrexate—urinary bladder cancer	4.14e-05	0.000296	CcSEcCtD
Mycophenolic acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	4.14e-05	0.000355	CbGpPWpGaD
Mycophenolic acid—Mediastinal disorder—Doxorubicin—urinary bladder cancer	4.13e-05	0.000295	CcSEcCtD
Mycophenolic acid—Leukopenia—Methotrexate—urinary bladder cancer	4.12e-05	0.000294	CcSEcCtD
Mycophenolic acid—Chills—Doxorubicin—urinary bladder cancer	4.11e-05	0.000294	CcSEcCtD
Mycophenolic acid—UGT1A7—Metabolism—GPX1—urinary bladder cancer	4.1e-05	0.000352	CbGpPWpGaD
Mycophenolic acid—Arrhythmia—Doxorubicin—urinary bladder cancer	4.09e-05	0.000292	CcSEcCtD
Mycophenolic acid—Nausea—Cisplatin—urinary bladder cancer	4.07e-05	0.000291	CcSEcCtD
Mycophenolic acid—Vision blurred—Epirubicin—urinary bladder cancer	4.06e-05	0.00029	CcSEcCtD
Mycophenolic acid—Alopecia—Doxorubicin—urinary bladder cancer	4.05e-05	0.000289	CcSEcCtD
Mycophenolic acid—UGT2B7—Metabolism—CYP4B1—urinary bladder cancer	4.04e-05	0.000347	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—ERCC2—urinary bladder cancer	4.03e-05	0.000346	CbGpPWpGaD
Mycophenolic acid—Cough—Methotrexate—urinary bladder cancer	4.02e-05	0.000287	CcSEcCtD
Mycophenolic acid—Mental disorder—Doxorubicin—urinary bladder cancer	4.01e-05	0.000287	CcSEcCtD
Mycophenolic acid—Ill-defined disorder—Epirubicin—urinary bladder cancer	4e-05	0.000286	CcSEcCtD
Mycophenolic acid—Convulsion—Methotrexate—urinary bladder cancer	3.99e-05	0.000285	CcSEcCtD
Mycophenolic acid—Vomiting—Etoposide—urinary bladder cancer	3.99e-05	0.000285	CcSEcCtD
Mycophenolic acid—Malnutrition—Doxorubicin—urinary bladder cancer	3.99e-05	0.000285	CcSEcCtD
Mycophenolic acid—UGT1A1—Metabolism—GSTO2—urinary bladder cancer	3.98e-05	0.000342	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—GSTO2—urinary bladder cancer	3.98e-05	0.000342	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—NAT1—urinary bladder cancer	3.98e-05	0.000342	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—NAT1—urinary bladder cancer	3.98e-05	0.000342	CbGpPWpGaD
Mycophenolic acid—Anaemia—Epirubicin—urinary bladder cancer	3.98e-05	0.000285	CcSEcCtD
Mycophenolic acid—IMPDH1—Metabolism—TYMS—urinary bladder cancer	3.96e-05	0.00034	CbGpPWpGaD
Mycophenolic acid—Agitation—Epirubicin—urinary bladder cancer	3.96e-05	0.000283	CcSEcCtD
Mycophenolic acid—Rash—Etoposide—urinary bladder cancer	3.95e-05	0.000283	CcSEcCtD
Mycophenolic acid—Dermatitis—Etoposide—urinary bladder cancer	3.95e-05	0.000282	CcSEcCtD
Mycophenolic acid—UGT1A6—Metabolism—HPGDS—urinary bladder cancer	3.93e-05	0.000338	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—ENO2—urinary bladder cancer	3.93e-05	0.000338	CbGpPWpGaD
Mycophenolic acid—Headache—Etoposide—urinary bladder cancer	3.93e-05	0.000281	CcSEcCtD
Mycophenolic acid—Flatulence—Doxorubicin—urinary bladder cancer	3.93e-05	0.000281	CcSEcCtD
Mycophenolic acid—Arthralgia—Methotrexate—urinary bladder cancer	3.92e-05	0.00028	CcSEcCtD
Mycophenolic acid—Chest pain—Methotrexate—urinary bladder cancer	3.92e-05	0.00028	CcSEcCtD
Mycophenolic acid—Myalgia—Methotrexate—urinary bladder cancer	3.92e-05	0.00028	CcSEcCtD
Mycophenolic acid—IMPDH1—Metabolism—NCOR1—urinary bladder cancer	3.92e-05	0.000337	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—GSTM1—urinary bladder cancer	3.92e-05	0.000337	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.92e-05	0.000336	CbGpPWpGaD
Mycophenolic acid—Tension—Doxorubicin—urinary bladder cancer	3.91e-05	0.00028	CcSEcCtD
Mycophenolic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	3.89e-05	0.000278	CcSEcCtD
Mycophenolic acid—Malaise—Epirubicin—urinary bladder cancer	3.89e-05	0.000278	CcSEcCtD
Mycophenolic acid—Discomfort—Methotrexate—urinary bladder cancer	3.87e-05	0.000277	CcSEcCtD
Mycophenolic acid—Nervousness—Doxorubicin—urinary bladder cancer	3.87e-05	0.000277	CcSEcCtD
Mycophenolic acid—Vertigo—Epirubicin—urinary bladder cancer	3.87e-05	0.000277	CcSEcCtD
Mycophenolic acid—Syncope—Epirubicin—urinary bladder cancer	3.86e-05	0.000276	CcSEcCtD
Mycophenolic acid—Leukopenia—Epirubicin—urinary bladder cancer	3.86e-05	0.000276	CcSEcCtD
Mycophenolic acid—Back pain—Doxorubicin—urinary bladder cancer	3.86e-05	0.000276	CcSEcCtD
Mycophenolic acid—Muscle spasms—Doxorubicin—urinary bladder cancer	3.83e-05	0.000274	CcSEcCtD
Mycophenolic acid—UGT1A6—Metabolism—GSTT1—urinary bladder cancer	3.82e-05	0.000328	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—SLC19A1—urinary bladder cancer	3.81e-05	0.000327	CbGpPWpGaD
Mycophenolic acid—Palpitations—Epirubicin—urinary bladder cancer	3.81e-05	0.000272	CcSEcCtD
Mycophenolic acid—Confusional state—Methotrexate—urinary bladder cancer	3.79e-05	0.000271	CcSEcCtD
Mycophenolic acid—Loss of consciousness—Epirubicin—urinary bladder cancer	3.79e-05	0.000271	CcSEcCtD
Mycophenolic acid—UGT1A7—Metabolism—MTHFR—urinary bladder cancer	3.79e-05	0.000325	CbGpPWpGaD
Mycophenolic acid—Cough—Epirubicin—urinary bladder cancer	3.76e-05	0.000269	CcSEcCtD
Mycophenolic acid—Vision blurred—Doxorubicin—urinary bladder cancer	3.76e-05	0.000268	CcSEcCtD
Mycophenolic acid—IMPDH1—Metabolism—GPX1—urinary bladder cancer	3.75e-05	0.000322	CbGpPWpGaD
Mycophenolic acid—Convulsion—Epirubicin—urinary bladder cancer	3.73e-05	0.000267	CcSEcCtD
Mycophenolic acid—Infection—Methotrexate—urinary bladder cancer	3.73e-05	0.000267	CcSEcCtD
Mycophenolic acid—Nausea—Etoposide—urinary bladder cancer	3.73e-05	0.000266	CcSEcCtD
Mycophenolic acid—Hypertension—Epirubicin—urinary bladder cancer	3.72e-05	0.000266	CcSEcCtD
Mycophenolic acid—UGT2B7—Metabolism—PRSS3—urinary bladder cancer	3.71e-05	0.000319	CbGpPWpGaD
Mycophenolic acid—Ill-defined disorder—Doxorubicin—urinary bladder cancer	3.7e-05	0.000264	CcSEcCtD
Mycophenolic acid—Nervous system disorder—Methotrexate—urinary bladder cancer	3.68e-05	0.000263	CcSEcCtD
Mycophenolic acid—Anaemia—Doxorubicin—urinary bladder cancer	3.68e-05	0.000263	CcSEcCtD
Mycophenolic acid—IMPDH1—Metabolism—ERCC2—urinary bladder cancer	3.68e-05	0.000316	CbGpPWpGaD
Mycophenolic acid—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.68e-05	0.000263	CcSEcCtD
Mycophenolic acid—Arthralgia—Epirubicin—urinary bladder cancer	3.67e-05	0.000262	CcSEcCtD
Mycophenolic acid—Chest pain—Epirubicin—urinary bladder cancer	3.67e-05	0.000262	CcSEcCtD
Mycophenolic acid—Myalgia—Epirubicin—urinary bladder cancer	3.67e-05	0.000262	CcSEcCtD
Mycophenolic acid—Agitation—Doxorubicin—urinary bladder cancer	3.66e-05	0.000262	CcSEcCtD
Mycophenolic acid—Anxiety—Epirubicin—urinary bladder cancer	3.66e-05	0.000261	CcSEcCtD
Mycophenolic acid—Skin disorder—Methotrexate—urinary bladder cancer	3.65e-05	0.000261	CcSEcCtD
Mycophenolic acid—UGT1A9—Metabolism—UGT2B7—urinary bladder cancer	3.64e-05	0.000313	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—UGT2B7—urinary bladder cancer	3.64e-05	0.000313	CbGpPWpGaD
Mycophenolic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	3.64e-05	0.00026	CcSEcCtD
Mycophenolic acid—Hyperhidrosis—Methotrexate—urinary bladder cancer	3.63e-05	0.00026	CcSEcCtD
Mycophenolic acid—Discomfort—Epirubicin—urinary bladder cancer	3.62e-05	0.000259	CcSEcCtD
Mycophenolic acid—Malaise—Doxorubicin—urinary bladder cancer	3.59e-05	0.000257	CcSEcCtD
Mycophenolic acid—Dry mouth—Epirubicin—urinary bladder cancer	3.59e-05	0.000256	CcSEcCtD
Mycophenolic acid—Vertigo—Doxorubicin—urinary bladder cancer	3.58e-05	0.000256	CcSEcCtD
Mycophenolic acid—Anorexia—Methotrexate—urinary bladder cancer	3.58e-05	0.000256	CcSEcCtD
Mycophenolic acid—Syncope—Doxorubicin—urinary bladder cancer	3.57e-05	0.000255	CcSEcCtD
Mycophenolic acid—Leukopenia—Doxorubicin—urinary bladder cancer	3.57e-05	0.000255	CcSEcCtD
Mycophenolic acid—Confusional state—Epirubicin—urinary bladder cancer	3.55e-05	0.000253	CcSEcCtD
Mycophenolic acid—Palpitations—Doxorubicin—urinary bladder cancer	3.52e-05	0.000252	CcSEcCtD
Mycophenolic acid—Oedema—Epirubicin—urinary bladder cancer	3.52e-05	0.000251	CcSEcCtD
Mycophenolic acid—Hypotension—Methotrexate—urinary bladder cancer	3.51e-05	0.000251	CcSEcCtD
Mycophenolic acid—Loss of consciousness—Doxorubicin—urinary bladder cancer	3.5e-05	0.00025	CcSEcCtD
Mycophenolic acid—Infection—Epirubicin—urinary bladder cancer	3.49e-05	0.00025	CcSEcCtD
Mycophenolic acid—Cough—Doxorubicin—urinary bladder cancer	3.48e-05	0.000249	CcSEcCtD
Mycophenolic acid—IMPDH1—Metabolism—MTHFR—urinary bladder cancer	3.46e-05	0.000297	CbGpPWpGaD
Mycophenolic acid—Shock—Epirubicin—urinary bladder cancer	3.46e-05	0.000247	CcSEcCtD
Mycophenolic acid—Convulsion—Doxorubicin—urinary bladder cancer	3.45e-05	0.000247	CcSEcCtD
Mycophenolic acid—Nervous system disorder—Epirubicin—urinary bladder cancer	3.45e-05	0.000246	CcSEcCtD
Mycophenolic acid—IMPDH2—Metabolism—PPARG—urinary bladder cancer	3.44e-05	0.000296	CbGpPWpGaD
Mycophenolic acid—Thrombocytopenia—Epirubicin—urinary bladder cancer	3.44e-05	0.000246	CcSEcCtD
Mycophenolic acid—Hypertension—Doxorubicin—urinary bladder cancer	3.44e-05	0.000246	CcSEcCtD
Mycophenolic acid—Tachycardia—Epirubicin—urinary bladder cancer	3.43e-05	0.000245	CcSEcCtD
Mycophenolic acid—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	3.42e-05	0.000245	CcSEcCtD
Mycophenolic acid—Skin disorder—Epirubicin—urinary bladder cancer	3.42e-05	0.000244	CcSEcCtD
Mycophenolic acid—Hyperhidrosis—Epirubicin—urinary bladder cancer	3.4e-05	0.000243	CcSEcCtD
Mycophenolic acid—Insomnia—Methotrexate—urinary bladder cancer	3.4e-05	0.000243	CcSEcCtD
Mycophenolic acid—Arthralgia—Doxorubicin—urinary bladder cancer	3.39e-05	0.000243	CcSEcCtD
Mycophenolic acid—Chest pain—Doxorubicin—urinary bladder cancer	3.39e-05	0.000243	CcSEcCtD
Mycophenolic acid—Myalgia—Doxorubicin—urinary bladder cancer	3.39e-05	0.000243	CcSEcCtD
Mycophenolic acid—Anxiety—Doxorubicin—urinary bladder cancer	3.38e-05	0.000242	CcSEcCtD
Mycophenolic acid—Paraesthesia—Methotrexate—urinary bladder cancer	3.37e-05	0.000241	CcSEcCtD
Mycophenolic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	3.37e-05	0.000241	CcSEcCtD
Mycophenolic acid—Discomfort—Doxorubicin—urinary bladder cancer	3.35e-05	0.00024	CcSEcCtD
Mycophenolic acid—Anorexia—Epirubicin—urinary bladder cancer	3.35e-05	0.00024	CcSEcCtD
Mycophenolic acid—Dyspnoea—Methotrexate—urinary bladder cancer	3.35e-05	0.000239	CcSEcCtD
Mycophenolic acid—Somnolence—Methotrexate—urinary bladder cancer	3.34e-05	0.000239	CcSEcCtD
Mycophenolic acid—Dry mouth—Doxorubicin—urinary bladder cancer	3.32e-05	0.000237	CcSEcCtD
Mycophenolic acid—IMPDH2—Metabolism—CREBBP—urinary bladder cancer	3.31e-05	0.000284	CbGpPWpGaD
Mycophenolic acid—Dyspepsia—Methotrexate—urinary bladder cancer	3.31e-05	0.000236	CcSEcCtD
Mycophenolic acid—Hypotension—Epirubicin—urinary bladder cancer	3.29e-05	0.000235	CcSEcCtD
Mycophenolic acid—Confusional state—Doxorubicin—urinary bladder cancer	3.28e-05	0.000234	CcSEcCtD
Mycophenolic acid—UGT1A1—Metabolism—CYP4B1—urinary bladder cancer	3.28e-05	0.000282	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—CYP4B1—urinary bladder cancer	3.28e-05	0.000282	CbGpPWpGaD
Mycophenolic acid—Decreased appetite—Methotrexate—urinary bladder cancer	3.27e-05	0.000233	CcSEcCtD
Mycophenolic acid—Oedema—Doxorubicin—urinary bladder cancer	3.25e-05	0.000233	CcSEcCtD
Mycophenolic acid—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.24e-05	0.000232	CcSEcCtD
Mycophenolic acid—Fatigue—Methotrexate—urinary bladder cancer	3.24e-05	0.000231	CcSEcCtD
Mycophenolic acid—Infection—Doxorubicin—urinary bladder cancer	3.23e-05	0.000231	CcSEcCtD
Mycophenolic acid—Pain—Methotrexate—urinary bladder cancer	3.21e-05	0.00023	CcSEcCtD
Mycophenolic acid—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	3.2e-05	0.000229	CcSEcCtD
Mycophenolic acid—Shock—Doxorubicin—urinary bladder cancer	3.2e-05	0.000229	CcSEcCtD
Mycophenolic acid—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.19e-05	0.000228	CcSEcCtD
Mycophenolic acid—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.19e-05	0.000228	CcSEcCtD
Mycophenolic acid—Insomnia—Epirubicin—urinary bladder cancer	3.18e-05	0.000227	CcSEcCtD
Mycophenolic acid—Tachycardia—Doxorubicin—urinary bladder cancer	3.18e-05	0.000227	CcSEcCtD
Mycophenolic acid—UGT1A6—Metabolism—NQO1—urinary bladder cancer	3.17e-05	0.000272	CbGpPWpGaD
Mycophenolic acid—Skin disorder—Doxorubicin—urinary bladder cancer	3.16e-05	0.000226	CcSEcCtD
Mycophenolic acid—Paraesthesia—Epirubicin—urinary bladder cancer	3.16e-05	0.000226	CcSEcCtD
Mycophenolic acid—Hyperhidrosis—Doxorubicin—urinary bladder cancer	3.15e-05	0.000225	CcSEcCtD
Mycophenolic acid—Dyspnoea—Epirubicin—urinary bladder cancer	3.13e-05	0.000224	CcSEcCtD
Mycophenolic acid—Somnolence—Epirubicin—urinary bladder cancer	3.13e-05	0.000223	CcSEcCtD
Mycophenolic acid—Anorexia—Doxorubicin—urinary bladder cancer	3.1e-05	0.000222	CcSEcCtD
Mycophenolic acid—UGT1A1—Metabolism—SLC19A1—urinary bladder cancer	3.1e-05	0.000266	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—SLC19A1—urinary bladder cancer	3.1e-05	0.000266	CbGpPWpGaD
Mycophenolic acid—Feeling abnormal—Methotrexate—urinary bladder cancer	3.1e-05	0.000221	CcSEcCtD
Mycophenolic acid—Dyspepsia—Epirubicin—urinary bladder cancer	3.1e-05	0.000221	CcSEcCtD
Mycophenolic acid—Gastrointestinal pain—Methotrexate—urinary bladder cancer	3.07e-05	0.00022	CcSEcCtD
Mycophenolic acid—UGT1A7—Metabolism—PPARG—urinary bladder cancer	3.07e-05	0.000264	CbGpPWpGaD
Mycophenolic acid—Decreased appetite—Epirubicin—urinary bladder cancer	3.06e-05	0.000218	CcSEcCtD
Mycophenolic acid—Hypotension—Doxorubicin—urinary bladder cancer	3.04e-05	0.000217	CcSEcCtD
Mycophenolic acid—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	3.04e-05	0.000217	CcSEcCtD
Mycophenolic acid—Fatigue—Epirubicin—urinary bladder cancer	3.03e-05	0.000217	CcSEcCtD
Mycophenolic acid—UGT1A1—Metabolism—PRSS3—urinary bladder cancer	3.02e-05	0.000259	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—PRSS3—urinary bladder cancer	3.02e-05	0.000259	CbGpPWpGaD
Mycophenolic acid—Constipation—Epirubicin—urinary bladder cancer	3.01e-05	0.000215	CcSEcCtD
Mycophenolic acid—Pain—Epirubicin—urinary bladder cancer	3.01e-05	0.000215	CcSEcCtD
Mycophenolic acid—Body temperature increased—Methotrexate—urinary bladder cancer	2.97e-05	0.000212	CcSEcCtD
Mycophenolic acid—Abdominal pain—Methotrexate—urinary bladder cancer	2.97e-05	0.000212	CcSEcCtD
Mycophenolic acid—UGT2B7—Metabolism—TYMP—urinary bladder cancer	2.97e-05	0.000255	CbGpPWpGaD
Mycophenolic acid—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	2.96e-05	0.000212	CcSEcCtD
Mycophenolic acid—UGT1A7—Metabolism—CREBBP—urinary bladder cancer	2.95e-05	0.000253	CbGpPWpGaD
Mycophenolic acid—Insomnia—Doxorubicin—urinary bladder cancer	2.94e-05	0.00021	CcSEcCtD
Mycophenolic acid—Paraesthesia—Doxorubicin—urinary bladder cancer	2.92e-05	0.000209	CcSEcCtD
Mycophenolic acid—Dyspnoea—Doxorubicin—urinary bladder cancer	2.9e-05	0.000207	CcSEcCtD
Mycophenolic acid—Feeling abnormal—Epirubicin—urinary bladder cancer	2.9e-05	0.000207	CcSEcCtD
Mycophenolic acid—Somnolence—Doxorubicin—urinary bladder cancer	2.89e-05	0.000207	CcSEcCtD
Mycophenolic acid—Gastrointestinal pain—Epirubicin—urinary bladder cancer	2.88e-05	0.000205	CcSEcCtD
Mycophenolic acid—Dyspepsia—Doxorubicin—urinary bladder cancer	2.86e-05	0.000205	CcSEcCtD
Mycophenolic acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	2.85e-05	0.000245	CbGpPWpGaD
Mycophenolic acid—Decreased appetite—Doxorubicin—urinary bladder cancer	2.83e-05	0.000202	CcSEcCtD
Mycophenolic acid—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.81e-05	0.000201	CcSEcCtD
Mycophenolic acid—IMPDH1—Metabolism—PPARG—urinary bladder cancer	2.81e-05	0.000241	CbGpPWpGaD
Mycophenolic acid—Fatigue—Doxorubicin—urinary bladder cancer	2.8e-05	0.0002	CcSEcCtD
Mycophenolic acid—Constipation—Doxorubicin—urinary bladder cancer	2.78e-05	0.000199	CcSEcCtD
Mycophenolic acid—Pain—Doxorubicin—urinary bladder cancer	2.78e-05	0.000199	CcSEcCtD
Mycophenolic acid—Body temperature increased—Epirubicin—urinary bladder cancer	2.78e-05	0.000199	CcSEcCtD
Mycophenolic acid—Abdominal pain—Epirubicin—urinary bladder cancer	2.78e-05	0.000199	CcSEcCtD
Mycophenolic acid—IMPDH2—Metabolism—PTGS2—urinary bladder cancer	2.71e-05	0.000233	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—CREBBP—urinary bladder cancer	2.7e-05	0.000232	CbGpPWpGaD
Mycophenolic acid—Asthenia—Methotrexate—urinary bladder cancer	2.7e-05	0.000193	CcSEcCtD
Mycophenolic acid—UGT2B7—Metabolism—NAT2—urinary bladder cancer	2.69e-05	0.000231	CbGpPWpGaD
Mycophenolic acid—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.68e-05	0.000192	CcSEcCtD
Mycophenolic acid—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.66e-05	0.00019	CcSEcCtD
Mycophenolic acid—Pruritus—Methotrexate—urinary bladder cancer	2.66e-05	0.00019	CcSEcCtD
Mycophenolic acid—UGT1A6—Metabolism—GSTP1—urinary bladder cancer	2.65e-05	0.000227	CbGpPWpGaD
Mycophenolic acid—Body temperature increased—Doxorubicin—urinary bladder cancer	2.57e-05	0.000184	CcSEcCtD
Mycophenolic acid—Abdominal pain—Doxorubicin—urinary bladder cancer	2.57e-05	0.000184	CcSEcCtD
Mycophenolic acid—Diarrhoea—Methotrexate—urinary bladder cancer	2.57e-05	0.000184	CcSEcCtD
Mycophenolic acid—Asthenia—Epirubicin—urinary bladder cancer	2.52e-05	0.00018	CcSEcCtD
Mycophenolic acid—Pruritus—Epirubicin—urinary bladder cancer	2.49e-05	0.000178	CcSEcCtD
Mycophenolic acid—Dizziness—Methotrexate—urinary bladder cancer	2.48e-05	0.000178	CcSEcCtD
Mycophenolic acid—UGT1A6—Metabolism—TYMS—urinary bladder cancer	2.46e-05	0.000211	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—GSTM1—urinary bladder cancer	2.43e-05	0.000209	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—NCOR1—urinary bladder cancer	2.43e-05	0.000209	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.42e-05	0.000208	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—PTGS2—urinary bladder cancer	2.42e-05	0.000207	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—TYMP—urinary bladder cancer	2.41e-05	0.000207	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—TYMP—urinary bladder cancer	2.41e-05	0.000207	CbGpPWpGaD
Mycophenolic acid—Diarrhoea—Epirubicin—urinary bladder cancer	2.41e-05	0.000172	CcSEcCtD
Mycophenolic acid—Vomiting—Methotrexate—urinary bladder cancer	2.39e-05	0.000171	CcSEcCtD
Mycophenolic acid—Rash—Methotrexate—urinary bladder cancer	2.37e-05	0.000169	CcSEcCtD
Mycophenolic acid—Dermatitis—Methotrexate—urinary bladder cancer	2.37e-05	0.000169	CcSEcCtD
Mycophenolic acid—IMPDH2—Metabolism—PTEN—urinary bladder cancer	2.36e-05	0.000203	CbGpPWpGaD
Mycophenolic acid—Headache—Methotrexate—urinary bladder cancer	2.35e-05	0.000168	CcSEcCtD
Mycophenolic acid—Asthenia—Doxorubicin—urinary bladder cancer	2.33e-05	0.000167	CcSEcCtD
Mycophenolic acid—UGT1A6—Metabolism—GPX1—urinary bladder cancer	2.33e-05	0.0002	CbGpPWpGaD
Mycophenolic acid—Dizziness—Epirubicin—urinary bladder cancer	2.33e-05	0.000166	CcSEcCtD
Mycophenolic acid—UGT2B7—Metabolism—RRM2—urinary bladder cancer	2.32e-05	0.000199	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.32e-05	0.000199	CbGpPWpGaD
Mycophenolic acid—Pruritus—Doxorubicin—urinary bladder cancer	2.3e-05	0.000164	CcSEcCtD
Mycophenolic acid—UGT1A6—Metabolism—ERCC2—urinary bladder cancer	2.29e-05	0.000196	CbGpPWpGaD
Mycophenolic acid—IMPDH2—Metabolism—EP300—urinary bladder cancer	2.25e-05	0.000194	CbGpPWpGaD
Mycophenolic acid—Vomiting—Epirubicin—urinary bladder cancer	2.24e-05	0.00016	CcSEcCtD
Mycophenolic acid—Nausea—Methotrexate—urinary bladder cancer	2.23e-05	0.000159	CcSEcCtD
Mycophenolic acid—Diarrhoea—Doxorubicin—urinary bladder cancer	2.23e-05	0.000159	CcSEcCtD
Mycophenolic acid—Rash—Epirubicin—urinary bladder cancer	2.22e-05	0.000158	CcSEcCtD
Mycophenolic acid—Dermatitis—Epirubicin—urinary bladder cancer	2.21e-05	0.000158	CcSEcCtD
Mycophenolic acid—IMPDH1—Metabolism—PTGS2—urinary bladder cancer	2.21e-05	0.00019	CbGpPWpGaD
Mycophenolic acid—Headache—Epirubicin—urinary bladder cancer	2.2e-05	0.000157	CcSEcCtD
Mycophenolic acid—UGT1A1—Metabolism—NAT2—urinary bladder cancer	2.18e-05	0.000187	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—NAT2—urinary bladder cancer	2.18e-05	0.000187	CbGpPWpGaD
Mycophenolic acid—Dizziness—Doxorubicin—urinary bladder cancer	2.15e-05	0.000154	CcSEcCtD
Mycophenolic acid—UGT1A6—Metabolism—MTHFR—urinary bladder cancer	2.15e-05	0.000184	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—HPGDS—urinary bladder cancer	2.15e-05	0.000184	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—ENO2—urinary bladder cancer	2.15e-05	0.000184	CbGpPWpGaD
Mycophenolic acid—UGT1A7—Metabolism—PTEN—urinary bladder cancer	2.11e-05	0.000181	CbGpPWpGaD
Mycophenolic acid—Nausea—Epirubicin—urinary bladder cancer	2.09e-05	0.000149	CcSEcCtD
Mycophenolic acid—UGT2B7—Metabolism—GSTT1—urinary bladder cancer	2.08e-05	0.000179	CbGpPWpGaD
Mycophenolic acid—Vomiting—Doxorubicin—urinary bladder cancer	2.07e-05	0.000148	CcSEcCtD
Mycophenolic acid—Rash—Doxorubicin—urinary bladder cancer	2.05e-05	0.000147	CcSEcCtD
Mycophenolic acid—Dermatitis—Doxorubicin—urinary bladder cancer	2.05e-05	0.000146	CcSEcCtD
Mycophenolic acid—Headache—Doxorubicin—urinary bladder cancer	2.04e-05	0.000146	CcSEcCtD
Mycophenolic acid—UGT1A7—Metabolism—EP300—urinary bladder cancer	2.01e-05	0.000173	CbGpPWpGaD
Mycophenolic acid—Nausea—Doxorubicin—urinary bladder cancer	1.93e-05	0.000138	CcSEcCtD
Mycophenolic acid—IMPDH1—Metabolism—PTEN—urinary bladder cancer	1.93e-05	0.000165	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—RRM2—urinary bladder cancer	1.88e-05	0.000162	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—RRM2—urinary bladder cancer	1.88e-05	0.000162	CbGpPWpGaD
Mycophenolic acid—IMPDH1—Metabolism—EP300—urinary bladder cancer	1.84e-05	0.000158	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—ENO2—urinary bladder cancer	1.74e-05	0.00015	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—HPGDS—urinary bladder cancer	1.74e-05	0.00015	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—ENO2—urinary bladder cancer	1.74e-05	0.00015	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—HPGDS—urinary bladder cancer	1.74e-05	0.00015	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—PPARG—urinary bladder cancer	1.74e-05	0.00015	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.73e-05	0.000149	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—NQO1—urinary bladder cancer	1.73e-05	0.000149	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—GSTT1—urinary bladder cancer	1.69e-05	0.000145	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—GSTT1—urinary bladder cancer	1.69e-05	0.000145	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—CREBBP—urinary bladder cancer	1.67e-05	0.000144	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.67e-05	0.000143	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—GSTP1—urinary bladder cancer	1.44e-05	0.000124	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—NQO1—urinary bladder cancer	1.41e-05	0.000121	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—NQO1—urinary bladder cancer	1.41e-05	0.000121	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—PTGS2—urinary bladder cancer	1.37e-05	0.000118	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.36e-05	0.000117	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—TYMS—urinary bladder cancer	1.34e-05	0.000115	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—NCOR1—urinary bladder cancer	1.33e-05	0.000114	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—GSTM1—urinary bladder cancer	1.33e-05	0.000114	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—GPX1—urinary bladder cancer	1.27e-05	0.000109	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—ERCC2—urinary bladder cancer	1.25e-05	0.000107	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—PTEN—urinary bladder cancer	1.2e-05	0.000103	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.19e-05	0.000102	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—GSTP1—urinary bladder cancer	1.17e-05	0.000101	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—GSTP1—urinary bladder cancer	1.17e-05	0.000101	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	1.17e-05	0.000101	CbGpPWpGaD
Mycophenolic acid—UGT1A6—Metabolism—EP300—urinary bladder cancer	1.14e-05	9.79e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.13e-05	9.75e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—TYMS—urinary bladder cancer	1.09e-05	9.37e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—TYMS—urinary bladder cancer	1.09e-05	9.37e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—NCOR1—urinary bladder cancer	1.08e-05	9.26e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—GSTM1—urinary bladder cancer	1.08e-05	9.26e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—GSTM1—urinary bladder cancer	1.08e-05	9.26e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—NCOR1—urinary bladder cancer	1.08e-05	9.26e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—GPX1—urinary bladder cancer	1.03e-05	8.87e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—GPX1—urinary bladder cancer	1.03e-05	8.87e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—ERCC2—urinary bladder cancer	1.01e-05	8.7e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—ERCC2—urinary bladder cancer	1.01e-05	8.7e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—MTHFR—urinary bladder cancer	9.53e-06	8.18e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—MTHFR—urinary bladder cancer	9.53e-06	8.18e-05	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—PPARG—urinary bladder cancer	9.51e-06	8.16e-05	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	9.13e-06	7.84e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—PPARG—urinary bladder cancer	7.72e-06	6.63e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—PPARG—urinary bladder cancer	7.72e-06	6.63e-05	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	7.48e-06	6.42e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	7.42e-06	6.37e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—CREBBP—urinary bladder cancer	7.42e-06	6.37e-05	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—PTEN—urinary bladder cancer	6.52e-06	5.6e-05	CbGpPWpGaD
Mycophenolic acid—UGT2B7—Metabolism—EP300—urinary bladder cancer	6.22e-06	5.34e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	6.08e-06	5.22e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—PTGS2—urinary bladder cancer	6.08e-06	5.22e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—PTEN—urinary bladder cancer	5.3e-06	4.55e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—PTEN—urinary bladder cancer	5.3e-06	4.55e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A1—Metabolism—EP300—urinary bladder cancer	5.05e-06	4.34e-05	CbGpPWpGaD
Mycophenolic acid—UGT1A9—Metabolism—EP300—urinary bladder cancer	5.05e-06	4.34e-05	CbGpPWpGaD
